skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors

Kelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support
Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support

Rizzieri, David A ; Chao, Nelson J

Current opinion in oncology, 1997-09, Vol.9 (5), p.420-427

United States: Lippincott-Raven Publishers

Texto completo disponível

Citações Citado por
3
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation

SNYDER, Matthew J ; STENZEL, Timothy T ; BUCKLEY, Patrick J ; LAGOO, Anand S ; RIZZIERI, David A ; GASPARETTO, Cristina ; VREDENBURGH, James J ; CHAO, Nelson J ; GONG, Jerald Z

The American journal of surgical pathology, 2004-06, Vol.28 (6), p.794-800 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
Prevention and treatment of graft-versus-host disease by pharmacologic agents
Prevention and treatment of graft-versus-host disease by pharmacologic agents
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevention and treatment of graft-versus-host disease by pharmacologic agents

Rizzieri, David A. ; Chao, Nelson J.

Current opinion in organ transplantation, 1998-06, Vol.3 (2), p.105-111

Texto completo disponível

Citações Citado por
5
Allogeneic Hematopoietic Stem Cell Transplant Using Mismatched/Haploidentical Donors
Allogeneic Hematopoietic Stem Cell Transplant Using Mismatched/Haploidentical Donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allogeneic Hematopoietic Stem Cell Transplant Using Mismatched/Haploidentical Donors

Koh, Liang-Piu ; Rizzieri, David A ; Chao, Nelson J

Biology of blood and marrow transplantation, 2007-11, Vol.13 (11), p.1249-1267

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Mechanisms of failure of chimeric antigen receptor T-cell therapy
Mechanisms of failure of chimeric antigen receptor T-cell therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mechanisms of failure of chimeric antigen receptor T-cell therapy

Li, Xiaoqing ; Chen, Weihong

Current opinion in hematology, 2019-11, Vol.26 (6), p.427-433

United States: Copyright Wolters Kluwer Health, Inc. All rights reserved

Texto completo disponível

Citações Citado por
7
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?

Rizzieri, David

Critical reviews in oncology/hematology, 2016-09, Vol.105, p.5-17 [Periódico revisado por pares]

Netherlands: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
8
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Pemmaraju, Naveen ; Sweet, Kendra L ; Stein, Anthony S ; Wang, Eunice S ; Rizzieri, David A ; Vasu, Sumithira ; Rosenblat, Todd L ; Brooks, Christopher L ; Habboubi, Nassir ; Mughal, Tariq I ; Kantarjian, Hagop ; Konopleva, Marina ; Lane, Andrew A

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3032-3036 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (878)

Data de Publicação 

De até
Refinar
  1. Antes de2001  (14)
  2. 2001Até2006  (40)
  3. 2007Até2012  (321)
  4. 2013Até2019  (444)
  5. Após 2019  (199)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.001)
  2. Japonês  (140)
  3. Português  (46)
  4. Espanhol  (5)
  5. Francês  (4)
  6. Alemão  (2)
  7. Polonês  (2)
  8. Chinês  (1)
  9. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.